Top

Published in:

01-12-2020 | Rheumatoid Arthritis | Review

Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression

Author: Moisés E. Bauer

Published in: Immunity & Ageing | Issue 1/2020

Abstract

Patients with rheumatoid arthritis (RA) develop features of accelerated ageing, including immunosenescence. These changes include decreased thymic functionality, expansion of late-differentiated effector T cells, increased telomeric attrition, and excessive production of cytokines (senescence-associated secretory phenotype). The progression of RA has been associated with the early development of age-related co-morbidities, including osteoporosis, cardiovascular complications, and cognitive impairment. Here I review data supporting the hypothesis that immune-senescence contributes to the aggravation of both articular and extra-articular manifestations. Of note, poor cognitive functions in RA were associated with senescent CD28- T cells, inflammaging, and autoantibodies against brain antigens. The pathways of immune-to-brain communication are discussed and provide the rationale for the cognitive impairment reported in RA.

Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Primer arthritis rheumatoid. Nat Rev Dis Prim. 2018;4:1–23. https://doi.org/10.1038/nrdp.2018.1.CrossRef

McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–19. https://doi.org/10.1056/nejmra1004965.CrossRefPubMed

Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmun Rev. 2011;11:123–31. https://doi.org/10.1016/j.autrev.2011.09.001.CrossRefPubMed

Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci U S A. 1989;86:636–40. https://doi.org/10.1073/pnas.86.2.636.CrossRefPubMedPubMedCentral

Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in balb/c mice. Arthritis Rheum. 1987;30:201–12. https://doi.org/10.1002/art.1780300211.CrossRefPubMed

Verheijden GFM, Rijnders AWM, Bos E, Coenen-De Roo CJJ, Van Staveren CJ, Miltenburg AMM, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum. 1997;40:1115–25. https://doi.org/10.1002/art.1780400616.CrossRefPubMed

Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30:1205–13. https://doi.org/10.1002/art.1780301102.CrossRefPubMed

Wang D, Zhang J, Lau J, Wang S, Taneja V, Matteson EL, et al. Mechanisms of lung disease development in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15:581–96. https://doi.org/10.1038/s41584-019-0275-x.CrossRefPubMed

Holmdahl R, Malmström V, Burkhardt H. Autoimmune priming, tissue attack and chronic inflammation - the three stages of rheumatoid arthritis. Eur J Immunol. 2014;44:1593–9. https://doi.org/10.1002/eji.201444486.CrossRefPubMed

10.

Burmester GR, Feist E, Dörner T. Emerging cell and cytokine targets in rheumatoid arthritis. Nat Rev Rheumatol. 2013;10:77–88. https://doi.org/10.1038/nrrheum.2013.168.CrossRefPubMed

11.

van Onna M, Boonen A. The challenging interplay between rheumatoid arthritis, ageing and comorbidities. BMC Musculoskelet Disord. 2016;17:184. https://doi.org/10.1186/s12891-016-1038-3.CrossRefPubMedPubMedCentral

12.

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–217. https://doi.org/10.1016/j.cell.2013.05.039.CrossRefPubMedPubMedCentral

13.

Chalan P, Van Den Berg A, Kroesen B-J, Brouwer L, Boots A. Rheumatoid arthritis, Immunosenescence and the hallmarks of aging. Curr Aging Sci. 2015;8:131–46.CrossRef

14.

Kirokawa K, Makinodan T. Thymic involution: effect on T cell differentiation. J Immunol. 1975;114:1659–64.

15.

Goronzy JJ, Shao L, Weyand CM. Immune aging and rheumatoid arthritis. Rheum Dis Clin N Am. 2010;36:297–310. https://doi.org/10.1016/j.rdc.2010.03.001.CrossRef

16.

Thewissen M, Somers V, Venken K, Linsen L, van Paassen P, Geusens P, et al. Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol. 2007;123:209–18. https://doi.org/10.1016/j.clim.2007.01.005.CrossRefPubMed

17.

Koetz K, Bryl E, Spickschen K, O’Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A. 2000;97:9203–8. https://doi.org/10.1073/pnas.97.16.9203.CrossRefPubMedPubMedCentral

18.

Pawlik A, Ostanek L, Brzosko I, Brzosko M, Masiuk M, Machalinski B, et al. The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis. Arthritis Res Ther. 2003;5. https://doi.org/10.1186/ar766.

19.

Petersen LE, Grassi-Oliveira R, Siara T, Ribeiro dos Santos SG, Ilha M, de Nardi T, et al. Premature Immunosenescence is associated with memory dysfunction in rheumatoid arthritis. Neuroimmunomodulation. 2015;22:130–7. https://doi.org/10.1159/000358437.CrossRefPubMed

20.

Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev. 2005;205:147–57.CrossRef

21.

Martens PB, Goronzy JJ, Schaid D, Weyand CM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum. 1997;40:1106–14. https://doi.org/10.1002/art.1780400615.CrossRefPubMed

22.

Pieper J, Johansson S, Snir O, Linton L, Rieck M, Buckner JH, et al. Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics. Scand J Immunol. 2014;79:149–55. https://doi.org/10.1111/sji.12139.CrossRefPubMedPubMedCentral

23.

Scarsi M, Ziglioli T, Airo P. Decreased circulating CD28-negative T cells in patients with rheumatoid arthritis treated with abatacept are correlated with clinical response. J Rheumatol. 2010;37:911–6. https://doi.org/10.3899/jrheum.091176.CrossRefPubMed

24.

Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A. 1998;95:14447–52. https://doi.org/10.1073/pnas.95.24.14447.CrossRefPubMedPubMedCentral

25.

Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708–12. https://doi.org/10.1038/44385.CrossRefPubMed

26.

Fann M, Chiu WK, Wood WH, Levine BL, Becker KG, Weng N-P. Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging. Immunol Rev. 2005;205:190–206. https://doi.org/10.1111/j.0105-2896.2005.00262.x.CrossRefPubMed

27.

Vallejo AN, Mueller RG, Hamel DL, Way A, Dvergsten JA, Griffin P, et al. Expansions of NK-like ␣␤ T cells with chronologic aging : Novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells. 2011;10:354–61. https://doi.org/10.1016/j.arr.2010.09.006.

28.

Fessler J, Raicht A, Husic R, Ficjan A, Schwarz C, Duftner C, et al. Novel senescent regulatory T-cell subset with impaired suppressive function in rheumatoid arthritis. Front Immunol. 2017;8:1–11. https://doi.org/10.3389/fimmu.2017.00300.CrossRef

29.

Del Rey MJ, Valín Á, Usategui A, Ergueta S, Martín E, Municio C, et al. Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype. Immun Ageing. 2019;16:1–9. https://doi.org/10.1186/s12979-019-0169-4.CrossRef

30.

Schönland SO, Lopez C, Widmann T, Zimmer J, Bryl E, Goronzy JJ, et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A. 2003. https://doi.org/10.1073/pnas.2233561100.

31.

Steer SE, Williams FMK, Kato B, Gardner JP, Norman PJ, Hall MA, et al. Reduced telomere length in rheumatoid arthritis is independent of disease activity and duration. Ann Rheum Dis. 2006;66:476–80. https://doi.org/10.1136/ard.2006.059188.CrossRefPubMedPubMedCentral

32.

Costenbader KH, Prescott J, Zee RY, De Vivo I. Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease? Autoimmun Rev. 2011;10:569–73. https://doi.org/10.1016/j.autrev.2011.04.034.CrossRefPubMedPubMedCentral

33.

Petersen LE, Schuch JB, de Azeredo LA, Baptista TSA, Motta JG, Do Prado AD, et al. Characterization of senescence biomarkers in rheumatoid arthritis: relevance to disease progression. Clin Rheumatol. 2019;38:2909–15. https://doi.org/10.1007/s10067-019-04615-0.CrossRefPubMed

34.

Fujii H, Shao L, Colmegna I, Goronzy JJ, Yand CM. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2009;106:4360–5. https://doi.org/10.1073/pnas.0811332106.CrossRefPubMedPubMedCentral

35.

Weng NP, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci U S A. 1997;94:10827–32. https://doi.org/10.1073/pnas.94.20.10827.CrossRefPubMedPubMedCentral

36.

Li Y, Shen Y, Hohensinner P, Ju J, Wen Z, Goodman SB, et al. Deficient activity of the nuclease MRE11A induces T cell aging and promotes Arthritogenic effector functions in patients with rheumatoid arthritis. Immunity. 2016;45:903–16. https://doi.org/10.1016/j.immuni.2016.09.013.CrossRefPubMedPubMedCentral

37.

Koch S, Larbi A, Özcelik D, Solana R, Gouttefangeas C, Attig S, et al. Cytomegalovirus infection: A driving force in human T cell immunosenescence. Ann N Y Acad Sci. 2007;1114:23–35. https://doi.org/10.1196/annals.1396.043.CrossRefPubMed

38.

Luz Correa B, Ornaghi AP, Cerutti Muller G, Engroff P, Pestana Lopes R, Gomes Da Silva Filho I, et al. The inverted CD4:CD8 ratio is associated with cytomegalovirus, poor cognitive and functional states in older adults. Neuroimmunomodulation. 2014;21:206–12. https://doi.org/10.1159/000356827.CrossRefPubMed

39.

Bano A, Pera A, Almoukayed A, Clarke THS, Kirmani S, Davies KA, et al. CD28null CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection [version 1; peer review: 2 approved]. F1000Research. 2019;8:1–13. https://doi.org/10.12688/f1000research.17119.1.CrossRef

40.

Fasth AER, Snir O, Johansson AAT, Nordmark B, Rahbar A, af Klint E, et al. Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis. Arthritis Res Ther 2007;9. doi: https://doi.org/10.1186/ar2286.

41.

Chanouzas D, Sagmeister M, Faustini S, Nightingale P, Richter A, Ferro CJ, et al. Subclinical Reactivation of Cytomegalovirus Drives CD4 + CD28 null T-Cell Expansion and Impaired Immune Response to Pneumococcal Vaccination in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. J Infect Dis. 2019;219(Oxford University Press):234–44. https://doi.org/10.1093/infdis/jiy493.CrossRefPubMed

42.

Maly K, Schirmer M. The story of CD4+CD28- T cells revisited: solved or still ongoing? J Immunol Res. 2015;2015. https://doi.org/10.1155/2015/348746.

43.

Pierer M, Rothe K, Quandt D, Schulz A, Rossol M, Scholz R, et al. Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis. Arthritis Rheum. 2012;64:1740–9. https://doi.org/10.1002/art.34346.CrossRefPubMed

44.

Broadley I, Pera A, Morrow G, Davies KA, Kern F. Expansions of cytotoxic CD4+CD28- T cells drive excess cardiovascular mortality in rheumatoid arthritis and other chronic inflammatory conditions and are triggered by CMV infection. Front Immunol. 2017;8:1–10. https://doi.org/10.3389/fimmu.2017.00195.CrossRef

45.

Almanzar G, Schmalzing M, Trippen R, Höfner K, Weißbrich B, Geissinger E, et al. Significant IFNγ responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis. J Clin Virol. 2016;77:77–84. https://doi.org/10.1016/j.jcv.2016.02.010.CrossRefPubMed

46.

Larionova RV, Arleevskaya MI, Kravtsova OA, Validov S, Renaudineau Y. In seroconverted rheumatoid arthritis patients a multi-reactive anti-herpes IgM profile is associated with disease activity. Clin Immunol. 2019;200:19–23. https://doi.org/10.1016/j.clim.2019.01.004.CrossRefPubMed

47.

Frimpong A, Kusi KA, Adu-Gyasi D, Amponsah J, Ofori MF, Ndifon W. Phenotypic evidence of T cell exhaustion and senescence during symptomatic plasmodium falciparum malaria. Front Immunol. 2019;10. https://doi.org/10.3389/fimmu.2019.01345.

48.

Caruso A, Fiorentini S, Licenziati S, Alessandri G, Ricotta D, Imberti L, et al. Expansion of rare CD8 +CD28 -CD11b - T cells with impaired effector functions in HIV-1-infected patients. J Acquir Immune Defic Syndr. 2000;24:465–74. https://doi.org/10.1097/00126334-200008150-00012.CrossRefPubMed

49.

Pillat MMM, Correa BLBL, da Rocha CFKCFK, Müller GCGC, Lopes RPRP, Lampert SSS, et al. Changes in T cell phenotype and activated MAPKs are correlated to impaired cellular responses to antigens and glucocorticoids during HTLV-I infection. J Neuroimmunol. 2009;216:76–84. https://doi.org/10.1016/j.jneuroim.2009.08.016.CrossRefPubMed

50.

Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JAE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303–7. https://doi.org/10.1161/01.CIR.0000054612.26458.B2.CrossRefPubMed

51.

Goronzy JJ, Matteson EL, Fulbright JW, Warrington KJ, Chang-Miller A, Hunder GG, et al. Prognostic markers of radiographic progression in early rheumatoid arthritis. Arthritis Rheum. 2004;50:43–54. https://doi.org/10.1002/art.11445.CrossRefPubMed

52.

Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CM, Goronzy JJ. Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis. Arthritis Rheum. 2005;52:2996–3003. https://doi.org/10.1002/art.21353.CrossRefPubMed

53.

Weng N, Akbar AN, Goronzy J. CD28- T cells : their role in the age- associated decline of immune function. Trends Immunol. 2009;30:306–12. https://doi.org/10.1016/j.it.2009.03.013.CrossRefPubMedPubMedCentral

54.

Sawai H, Park YW, Roberson J, Imai T, Goronzy JJ, Weyand CM. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2005;52:1392–401. https://doi.org/10.1002/art.21140.CrossRefPubMed

55.

Fessler J, Husic R, Schwetz V, Lerchbaum E, Aberer F, Fasching P, et al. Senescent T-cells promote bone loss in rheumatoid arthritis. Front Immunol. 2018;9:1–9. https://doi.org/10.3389/fimmu.2018.00095.CrossRef

56.

Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:1–14. https://doi.org/10.1038/s41413-018-0016-9.CrossRef

57.

Steffen U, Schett G, Bozec A. How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis. Front Immunol. 2019;10. https://doi.org/10.3389/fimmu.2019.01483.

58.

Sargin G, Kose R, Senturk T. Relationship between bone mineral density and anti-citrullinated protein antibody and rheumatoid factor in patients with rheumatoid arthritis. Eur J Rheumatol. 2019;6:29–32. https://doi.org/10.5152/eurjrheum.2018.18099.CrossRefPubMed

59.

Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis. 2014;73:854–60. https://doi.org/10.1136/annrheumdis-2012-202958.CrossRefPubMed

60.

Maruotti N, Corrado A, Cantatore FP. Osteoporosis and rheumatic diseases. Reumatismo. 2014;66:125–35. https://doi.org/10.4081/reumatismo.2014.785.CrossRefPubMed

61.

Heinlen L, Humphrey MB. Skeletal complications of rheumatoid arthritis. Osteoporos Int. 2017;28:2801–12. https://doi.org/10.1007/s00198-017-4170-5.CrossRefPubMed

62.

Crowson CS, Liao KP, Davis JM, Solomon DH, Matteson EL, Knutson KL, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013;166:622–8. https://doi.org/10.1016/j.ahj.2013.07.010.CrossRefPubMedPubMedCentral

63.

Fabbri E, An Y, Zoli M, Simonsick EM, Guralnik JM, Bandinelli S, et al. Aging and the burden of multimorbidity: associations with inflammatory and anabolic hormonal biomarkers. J Gerontol Ser A. 2015;70:63–70. https://doi.org/10.1093/gerona/glu127.CrossRef

64.

Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505–22. https://doi.org/10.1038/s41569-018-0064-2.CrossRefPubMedPubMedCentral

65.

Solomon DH, Reed GW, Kremer JM, Curtis JR, Farkouh ME, Harrold LR, et al. Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol. 2015;67:1449–55. https://doi.org/10.1002/art.39098.CrossRefPubMedPubMedCentral

66.

Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol. 2018;18:733–44. https://doi.org/10.1038/s41577-018-0065-8.CrossRefPubMed

67.

Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, et al. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation. 2004;109:2744–8. https://doi.org/10.1161/01.CIR.0000131450.66017.B3.CrossRefPubMed

68.

Liuzzo G, Kopecky SL, Frye RL, O’Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135–9. https://doi.org/10.1161/01.CIR.100.21.2135.CrossRefPubMed

69.

Alber HF, Duftner C, Wanitschek M, Dörler J, Schirmer M, Suessenbacher A, et al. Neopterin, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease. Int J Cardiol. 2009;135:27–35. https://doi.org/10.1016/j.ijcard.2008.03.010.CrossRefPubMed

70.

Dumitriu IE, Araguás ET, Baboonian C, Kaski JC. CD4+CD28null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res. 2009;81:11–9. https://doi.org/10.1093/cvr/cvn248.CrossRefPubMed

71.

Koller L, Richter B, Goliasch G, Blum S, Korpak M, Zorn G, et al. CD4+CD28null cells are an independent predictor of mortality in patients with heart failure. Atherosclerosis. 2013;230:414–6. https://doi.org/10.1016/j.atherosclerosis.2013.08.008.CrossRefPubMed

72.

Xing GQ, Russell S, Webster MJ, Post RM. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol. 2004;7:143–53. https://doi.org/10.1017/S1461145703004000.CrossRefPubMed

73.

Degré M. Has cytomegalovirus infection any role in the development of atherosclerosis? Clin Microbiol Infect. 2002;8:191–5. https://doi.org/10.1046/j.1469-0691.2002.00407.x.CrossRefPubMed

74.

Cheng J, Ke Q, Jin Z, Wang H, Kocher O, Morgan JP, et al. Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog. 2009;5. https://doi.org/10.1371/journal.ppat.1000427.

75.

Pachnio A, Ciaurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus infection leads to development of high frequencies of cytotoxic virus-specific CD4+ T cells targeted to vascular endothelium. PLoS Pathog. 2016;12. https://doi.org/10.1371/journal.ppat.1005832.

76.

Yurochko AD, Hwang ES, Rasmussen L, Keay S, Pereira L, Huang ES. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol. 1997;71:5051–9. https://doi.org/10.1128/jvi.71.7.5051-5059.1997.CrossRefPubMedPubMedCentral

77.

Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet. 2001;358:472–3. https://doi.org/10.1016/S0140-6736(01)05633-1.CrossRefPubMed

78.

Ormseth MJ, Solus JF, Oeser AM, Bian A, Gebretsadik T, Shintani A, et al. Telomere length and coronary atherosclerosis in rheumatoid arthritis. J Rheumatol. 2016;43:1469–74. https://doi.org/10.3899/jrheum.151115.CrossRefPubMedPubMedCentral

79.

Prelog M. Aging of the immune system: A risk factor for autoimmunity? Autoimmun Rev. 2006;5:136–9. https://doi.org/10.1016/j.autrev.2005.09.008.CrossRefPubMed

80.

Petersen LE, Baptista TSA, Molina JK, Motta JG, do Prado A, Piovesan DM, et al. Cognitive impairment in rheumatoid arthritis: role of lymphocyte subsets, cytokines and neurotrophic factors. Clin Rheumatol. 2018;37:1171–81. https://doi.org/10.1007/s10067-018-3990-9.CrossRefPubMed

81.

Appenzeller S, Bértolo MB, Costallat LTL. Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol. 2004;26:339–43. https://doi.org/10.1358/mf.2004.26.5.831324.CrossRefPubMed

82.

Said FA, Betoni TB, Magalhaes V, Nisihara R, Skare TL. Rheumatoid arthritis and cognition dysfunction: lack of association with cumulative glucocorticoid use. Immunopharmacol Immunotoxicol. 2019;41:565–7. https://doi.org/10.1080/08923973.2019.1679170.CrossRefPubMed

83.

Trollor JN, Smith E, Agars E, Kuan SA, Baune BT, Campbell L, et al. The association between systemic inflammation and cognitive performance in the elderly: the Sydney memory and ageing study. Age (Omaha). 2012;34:1295–308. https://doi.org/10.1007/s11357-011-9301-x.CrossRef

84.

Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Penttilã IM, Helkala EL, et al. Serum high sensitivity C-reactive protein and cognitive function in elderly women. Age Ageing. 2007;36:443–8. https://doi.org/10.1093/ageing/afm051.CrossRefPubMed

85.

van den Kommer TN, Dik MG, Comijs HC, Jonker C, Deeg DJH. Homocysteine and inflammation: predictors of cognitive decline in older persons? Neurobiol Aging. 2010;31:1700–9. https://doi.org/10.1016/j.neurobiolaging.2008.09.009.CrossRefPubMed

86.

Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005;26:485–95. https://doi.org/10.1016/j.it.2005.07.004.CrossRefPubMed

87.

Warren-Gash C, Forbes HJ, Williamson E, Breuer J, Hayward AC, Mavrodaris A, et al. Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2019;9. https://doi.org/10.1038/s41598-019-41218-w.

88.

Baptista TSA, Petersen LE, Molina JK, de Nardi T, Wieck A, do Prado A, et al. Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis. Clin Rheumatol. 2017;36:1959–68. https://doi.org/10.1007/s10067-017-3724-4.CrossRefPubMed

89.

Hagberg H, Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol. 2005;18:117–23. https://doi.org/10.1097/01.wco.0000162851.44897.8f.CrossRefPubMed

90.

Hamed SA, Selim ZI, Elattar AM, Elserogy YM, Ahmed EA, Mohamed HO. Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis. Clin Rheumatol. 2012;31:123–32. https://doi.org/10.1007/s10067-011-1795-1.CrossRefPubMed

91.

Joaquim AF, Appenzeller S. Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun Rev. 2015;14:1116–22. https://doi.org/10.1016/j.autrev.2015.07.015.CrossRefPubMed

92.

Matcham F, Davies R, Hotopf M, Hyrich KL, Norton S, Steer S, et al. The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register. Rheumatol (United Kingdom). 2018;57:835–43. https://doi.org/10.1093/rheumatology/kex528.CrossRef

93.

Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatol (United Kingdom) 2013;52:36–48. doi: https://doi.org/10.1093/rheumatology/ket169.

94.

Nerurkar L, Siebert S, McInnes IB, Cavanagh J. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry. 2019;6:164–73. https://doi.org/10.1016/S2215-0366(18)30255-4.CrossRefPubMed

95.

Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732–741. https://doi.org/S0006-3223(08)01532-1 [pii]https://doi.org/10.1016/j.biopsych.2008.11.029.

96.

qi FK, yuan LY, li WH, tao MX, xin GJ, Wang F, et al. Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior. Cell. 2019;179:864–879.e19. https://doi.org/10.1016/j.cell.2019.10.001.CrossRef

97.

Kapoor SR, Filer A, Fitzpatrick MA, Fisher BA, Taylor PC, Buckley CD, et al. Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis. Arthritis Rheum. 2013;65:1448–56. https://doi.org/10.1002/art.37921.CrossRefPubMedPubMedCentral

98.

Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019;20:928–42. https://doi.org/10.1038/s41590-019-0378-1.CrossRefPubMedPubMedCentral

99.

Duggal NA, Upton J, Phillips AC, Hampson P, Lord JM. Depressive symptoms post hip fracture in older adults are associated with phenotypic and functional alterations in T cells. Immun Ageing. 2014;11:1–16. https://doi.org/10.1186/s12979-014-0025-5.CrossRef

100.

Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci. 2018;1437:57–67. https://doi.org/10.1111/nyas.13712.CrossRefPubMed

101.

Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46–56. https://doi.org/nrn2297 [pii]https://doi.org/10.1038/nrn2297.

102.

Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34. https://doi.org/10.1038/nri.2015.5.CrossRefPubMedPubMedCentral

103.

Steiner J, Walter M, Gos T, Guillemin GJ, Bernstein HG, Sarnyai Z, et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation. 2011;8:94. https://doi.org/10.1186/1742-2094-8-94.CrossRefPubMedPubMedCentral

104.

Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002;5:405–14. https://doi.org/10.1038/nn835.CrossRefPubMed

105.

Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007;21:736–45. https://doi.org/10.1016/j.bbi.2007.03.008.CrossRefPubMedPubMedCentral

106.

Di Benedetto S, Müller L, Wenger E, Düzel S, Pawelec G. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. Neurosci Biobehav Rev. 2017;75:114–28. https://doi.org/10.1016/j.neubiorev.2017.01.044.CrossRefPubMed

107.

Guan Z, Fang J. Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun. 2006;20:64–71. https://doi.org/10.1016/j.bbi.2005.04.005.CrossRefPubMed

108.

Grimsholm O, Rantapää-Dahlqvist S, Dalén T, Forsgren S. BDNF in RA: Downregulated in plasma following anti-TNF treatment but no correlation with inflammatory parameters. Clin Rheumatol. 2008;27:1289–97. https://doi.org/10.1007/s10067-008-0910-4.CrossRefPubMed

109.

Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WEF, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation? J Exp Med. 1999;189:865–70. https://doi.org/10.1084/jem.189.5.865.CrossRefPubMedPubMedCentral

110.

Appel E, Kolman O, Kazimirsky G, Blumberg PM, Brodie C. Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. Neuroreport. 1997;8:3309–12. https://doi.org/10.1097/00001756-199710200-00023.CrossRefPubMed

111.

Goehler LE, Gaykema RP, Nguyen KT, Lee JE, Tilders FJ, Maier SF, et al. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J Neurosci. 1999;19:2799–806.CrossRef

112.

Blalock JE. The immune system as a sensory organ. J Immunol. 1984;132:1067–70.PubMed

113.

Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol. 2012;8:743–54. https://doi.org/10.1038/nrendo.2012.189.CrossRefPubMedPubMedCentral

114.

Tracey KJ. The inflammatory reflex. Nature. 2002;420:853–9. https://doi.org/10.1038/nature01321.CrossRefPubMed

115.

Rosas-Ballina M, Olofsson PS, Ochani M, Valdes-Ferrer SI, Levine YA, Reardon C, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science (80- ). 2011;334:98–101. https://doi.org/10.1126/science.1209985.CrossRef

116.

Watkins LR, Maier SF. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol. 2000;51:29–57. https://doi.org/10.1146/annurev.psych.51.1.29.CrossRefPubMed

117.

Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384–8. https://doi.org/10.1038/nature01339.CrossRefPubMed

118.

von Känel R, Nelesen RA, Mills PJ, Ziegler MG, Dimsdale JE. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav Immun. 2008;22:461–8. https://doi.org/10.1016/j.bbi.2007.09.009.CrossRef

119.

Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med. 2009;265:439–47. https://doi.org/10.1111/j.1365-2796.2008.02023.x.CrossRefPubMed

120.

Lindgren S, Stewenius J, Sjölund K, Lilja B, Sundkvist G. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol. 1993;28:638–42. https://doi.org/10.3109/00365529309096103.CrossRefPubMed

121.

Stein KS, McFarlane IC, Goldberg N, Ginzler EM. Heart rate variability in patients with systemic lupus erythematosus. Lupus. 1996;5:44–8.CrossRef

122.

Evrengül H, Dursunoglu D, Cobankara V, Polat B, Seleci D, Kabukçu S, et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol Int. 2004;24:198–202. https://doi.org/10.3329/jbsp.v7i2.14455.CrossRefPubMed

123.

Koopman FA, Chavan SS, Miljko S, Grazio S, Sokolovic S, Schuurman PR, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113:8284–9. https://doi.org/10.1073/pnas.1605635113.CrossRefPubMedPubMedCentral

124.

Schwartz M, Kipnis J, Rivest S, Prat A. How do immune cells support and shape the brain in health, disease, and aging? J Neurosci. 2013;33:17587–96. https://doi.org/10.1523/JNEUROSCI.3241-13.2013.CrossRefPubMedPubMedCentral

125.

Sawada A, Niiyama Y, Ataka K, Nagaishi K, Yamakage M, Fujimiya M. Suppression of bone marrow-derived microglia in the amygdala improves anxiety-like behavior induced by chronic partial sciatic nerve ligation in mice. Pain. 2014;155:1762–72. https://doi.org/10.1016/j.pain.2014.05.031.CrossRefPubMed

126.

Degos V, Vacas S, Han Z, van Rooijen N, Gressens P, Su H, et al. Depletion of bone marrow-derived macrophages perturbs the innate immune response to surgery and reduces postoperative memory dysfunction. Anesthesiology. 2013;118:527–36. https://doi.org/10.1097/ALN.0b013e3182834d94.CrossRefPubMedPubMedCentral

127.

Wohleb ES, McKim DB, Sheridan JF, Godbout JP. Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci. 2014;8:447. https://doi.org/10.3389/fnins.2014.00447.CrossRefPubMed

128.

Giunta B, Fernandez F, Nikolic WV, Obregon D, Rrapo E, Town T, et al. Inflammaging as a prodrome to Alzheimer’s disease. J Neuroinflammation. 2008;5:1–15. https://doi.org/10.1186/1742-2094-5-51.CrossRef

129.

Cohen H, Ziv Y, Cardon M, Kaplan Z, Matar MA, Gidron Y, et al. Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J Neurobiol. 2006;66:552–63. https://doi.org/10.1002/neu.20249.CrossRefPubMed

130.

Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci U S A. 2004;101:8180–5. https://doi.org/10.1073/pnas.0402268101.CrossRefPubMedPubMedCentral

131.

Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci. 2006;9:268–75. https://doi.org/10.1038/nn1629.CrossRefPubMed

132.

Kipnis J, Gadani S, Derecki NC. Pro-cognitive properties of T cells. Nat Rev Immunol. 2012;12:663–9. https://doi.org/10.1038/nri3280.CrossRefPubMedPubMedCentral

133.

Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR, et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med. 2010;207:1067–80. https://doi.org/10.1084/jem.20091419.CrossRefPubMedPubMedCentral

134.

Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, et al. Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science (80- ). 2014;346:89–93. https://doi.org/10.1126/science.1252945.CrossRef

135.

Ribeiro M, Brigas HC, Temido-Ferreira M, Pousinha PA, Regen T, Santa C, et al. Meningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci Immunol. 2019;4:1–13.CrossRef

136.

Li Y, Shen Y, Jin K, Wen Z, Cao W, Wu B, et al. The DNA Repair Nuclease MRE11A Functions as a Mitochondrial Protector and Prevents T Cell Pyroptosis and Tissue Inflammation. Cell Metab. 2019;30:477–492.e6. https://doi.org/10.1016/j.cmet.2019.06.016.CrossRefPubMed

137.

Raveney BJE, Oki S, Hohjoh H, Nakamura M, Sato W, Murata M, et al. Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation. Nat Commun. 2015;6:1–11. https://doi.org/10.1038/ncomms9437.CrossRef

138.

Chemin K, Ramsköld D, Diaz-Gallo LM, Herrath J, Houtman M, Tandre K, et al. EOMES-positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriers. Eur J Immunol. 2018;48:655–69. https://doi.org/10.1002/eji.201747296.CrossRefPubMed

139.

do Prado CH, Rizzo LB, Wieck A, Lopes RP, Teixeira AL, Grassi-Oliveira R, et al. Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder. Psychoneuroendocrinology. 2013;38:667–76. https://doi.org/10.1016/j.psyneuen.2012.08.005.CrossRefPubMed

140.

Do Prado CH, Grassi-Oliveira R, Daruy-Filho L, Wieck A, Bauer ME. Evidence for immune activation and resistance to glucocorticoids following childhood maltreatment in adolescents without psychopathology. Neuropsychopharmacology. 2017;42:2272–82. https://doi.org/10.1038/npp.2017.137.CrossRefPubMedPubMedCentral

141.

Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, et al. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild alzheimer’s disease. J Alzheimers Dis. 2009;17:91–103. https://doi.org/10.3233/JAD-2009-1015.CrossRefPubMed

142.

Pellicanò M, Larbi A, Goldeck D, Colonna-Romano G, Buffa S, Bulati M, et al. Immune profiling of Alzheimer patients. J Neuroimmunol. 2012;242:52–9. https://doi.org/10.1016/j.jneuroim.2011.11.005.CrossRefPubMed

Title: Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression
Author: Moisés E. Bauer
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Rheumatoid Arthritis
Cytokines
Published in: Immunity & Ageing / Issue 1/2020
Electronic ISSN: 1742-4933
DOI: https://doi.org/10.1186/s12979-020-00178-w

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2020

The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route

Immune cell extracellular vesicles and their mitochondrial content decline with ageing

A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging?

Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults

Plasma level of lipocalin 2 is increased in neovascular age-related macular degeneration patients, particularly those with macular fibrosis

COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage